SAN FRANCISCO (MedPage Today) -- One in five clinical trials in genitourinary cancers ended prematurely for reasons other than efficacy or toxicity, a review of almost 8,000 trials in adult cancer showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment